Abstract
BackgroundT-cell immunoreceptor with Ig and ITIM domains (TIGIT) is an important negative regulator of the immune response to cancer that contributes to resistance/relapse to anti-PD-1 therapy.1 In clinical trials, anti-human...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have